Evidence map›Paper›PMID 42100060›Full record

ArticleMediterranean journal of rheumatology2026

Real-World Effectiveness of MEpolizuMaB in Eosinophilic Granulomatosis with Polyangiitis in Greece: A Protocol for a Multicentre Retrospective Observational Study - The MEMBER Study.

Christos Koutsianas, Katerina Antoniou, Dimitrios Boumpas, Theodoros Dimitroulas, Christina G Katsiari, Menelaos Manoussakis, Kostantinos Porpodis, Kostantinos Samitas, Paschalis Steiropoulos, Paraskevi V Voulgari and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Mediterranean journal of rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Christos KoutsianasJoint Academic Rheumatology Program, Clinical Immunology-Rheumatology Unit, 2 Department of Medicine and Laboratory, National and Kapodistrian University of Athens, School of Medicine, General Hospital of Athens "Hippokration", Athens, Greece.
Katerina AntoniouRespiratory Medicine School of Medicine, Laboratory of Molecular and Cellular Pneumonology, School of Medicine, University of Crete, Heraklion, Greece.
Dimitrios BoumpasJoint Academic Rheumatology Program, 4 Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
Theodoros Dimitroulas4 Department of Internal Medicine, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Christina G KatsiariDepartment of Rheumatology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece.
Menelaos ManoussakisJoint Academic Rheumatology Program, Clinical Immunology-Rheumatology Unit, Department of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, Greece.
Kostantinos PorpodisPulmonary Department, Aristotle University of Thessaloniki, G. Papanikolaou Hospital, Thessaloniki, Greece.
Kostantinos Samitas7 Respiratory Medicine Dept and Asthma Centre Athens Chest Hospital "Sotiria", Athens, Greece.
Paschalis SteiropoulosDepartment of Respiratory Medicine, Medical School, University General Hospital, Democritus University of Thrace, Alexandroupolis, Greece.
Paraskevi V VoulgariDepartment of Rheumatology, School of Health Sciences, Faculty of Medicine, University of Ioannina, Ioannina, Greece.
Zafeiris LouvarisMedical Affairs, GSK, Athens, Greece.
Dimitrios VassilopoulosJoint Academic Rheumatology Program, Clinical Immunology-Rheumatology Unit, 2 Department of Medicine and Laboratory, National and Kapodistrian University of Athens, School of Medicine, General Hospital of Athens "Hippokration", Athens, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare systemic vasculitis occurring predominantly in patients with eosinophilic asthma. Glucocorticoids (GCs) are the cornerstone of treatment for EGPA to achieve disease remission, however, relapses despite GCs therapy are common. Mepolizumab (Nucala

Indexed as

EGPAglucocorticoidsinterleukin-5Mepolizumab (Nucala®)remissionvasculitides

Identifiers

PMID42100060
PMCPMC13145276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.